The BC Cancer Foundation is conducting a trial at BC Cancer Victoria to reduce prostate cancer radiation therapy visits from five to two, starting in Dec. 2024.
“People, particularly with prostate cancer, and melanoma, lung cancer, survival rates, are just so much better,” he said. “When I started, you know, people with melanoma that spread often didn’t live very long, with survival rates of like a year.” The new trial will run for eight years, and according to Alexander, there are plenty of reasons to be excited about the latest research.Alexander works alongside a team of six oncologists, two or three medical physicists, 10 radiation therapists and four or five nurses at BC Cancer Victoria.
The trials are randomized, and patients undergoing standard treatments can be allowed to participate in the clinical trials offered by BC Cancer.